PHENTOLAMINE Drug Patent Profile
✉ Email this page to a colleague
When do Phentolamine patents expire, and when can generic versions of Phentolamine launch?
Phentolamine is a drug marketed by Hikma and Precision Dose Inc and is included in two NDAs.
The generic ingredient in PHENTOLAMINE is phentolamine mesylate. There are four drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the phentolamine mesylate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Phentolamine
A generic version of PHENTOLAMINE was approved as phentolamine mesylate by HIKMA on March 11th, 1998.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PHENTOLAMINE?
- What are the global sales for PHENTOLAMINE?
- What is Average Wholesale Price for PHENTOLAMINE?
Summary for PHENTOLAMINE
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Drug Prices: | Drug price information for PHENTOLAMINE |
| DailyMed Link: | PHENTOLAMINE at DailyMed |
US Patents and Regulatory Information for PHENTOLAMINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hikma | PHENTOLAMINE MESYLATE | phentolamine mesylate | INJECTABLE;INJECTION | 040235-001 | Mar 11, 1998 | AP | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Precision Dose Inc | PHENTOLAMINE MESYLATE | phentolamine mesylate | INJECTABLE;INJECTION | 207686-001 | Jul 14, 2017 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
